But when clicking on the article, the opening sentence is, "As rates of sexually transmitted infections continue to skyrocket across the United States, a growing number of physicians are prescribing a commonly used antibiotic as a way to prevent chlamydia, gonorrhea and syphilis infections in gay and bisexual men and transgender women."
So immediately I'm wondering, "Is this reported rise only being seen amongst men or is it just men that have a readily available medical option?"
Still not entirely sure. Women are not mentioned in the entire article. But San Francisco is. A bunch of times.
So is this an everyone everywhere problem? Or is this a "men in San Francisco" problem? 🤔
@GalacticTurtle@Flick I don't like the "per 100,000" when we are dealing with cities of vastly different sizes. Jackson has a population of 153,701. This is the Bill Gates Fallacy, extremes happen in small cities/regions and it is PROOF OF NOTHING.
Doxy-PEP has not been shown to prevent bacterial STIs in the setting of vaginal receptive sex and is not currently recommended for cisgender women. A study in cisgender women in Kenya was recently reported at CROI 2023: it showed no protective effect.